Replies to post #21589 on Elite Pharmaceuticals Inc (ELTP)

[lasers]

Elite is converting the B & C to Common shs to get rid of the Preferreds. Elite is moving from a position of strength so that the next deal is a Pharma deal as I previously posted.

Third Party Funding for ELI-154 and ELI-216


Elite has developed ELI-154 and ELI-216 and retains the rights to these products. Elite has chosen to develop these products itself but expects to license these products at a later date to a third party who could provide funding for the remaining clinical studies, including a Phase III study, and who could provide sales and distribution for the product.


Page 11 & 12

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=8346235

How about more like this as a speculation?

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76918558